Actinogen Medical Ltd ACW:ASX

*Data is delayed | Exchange | AUD
Last | 4:10 PM AET
0.029quote price arrow down-0.001 (-3.33%)
Volume
1,874,188
52 week range
0.01 - 0.06
Loading...
  • Open0.03
  • Day High0.0305
  • Day Low0.0285
  • Prev Close0.03
  • 52 Week High0.06
  • 52 Week High Date04/18/23
  • 52 Week Low0.01
  • 52 Week Low Date10/19/23

Key Stats

  • Market Cap47.82M
  • Shares Out2,307.31M
  • 10 Day Average Volume3.16M
  • Dividend-
  • Dividend Yield-
  • Beta2.32
  • YTD % Change31.82

KEY STATS

  • Open0.03
  • Day High0.0305
  • Day Low0.0285
  • Prev Close0.03
  • 52 Week High0.06
  • 52 Week High Date04/18/23
  • 52 Week Low0.01
  • 52 Week Low Date10/19/23
  • Market Cap47.82M
  • Shares Out2,307.31M
  • 10 Day Average Volume3.16M
  • Dividend-
  • Dividend Yield-
  • Beta2.32
  • YTD % Change31.82

RATIOS/PROFITABILITY

  • EPS (TTM)-0.01
  • P/E (TTM)-3.87
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Actinogen Medical Ltd

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Actinogen Medical Limited is an Australia-based biotechnology company. The Company is engaged in the development of a therapy for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol. The Company is engaged in the development of its lead compound, Xanamem, as a therapy for Alzheimer’s Disease, Major Depressive Disorder, Fragile X Syndrome, and other neurological diseases where reducing cortisol inside brain cells could have a positive impact....
Geoffrey Brooke M.D.
Non-Executive Chairman of the Board
Steven Gourlay
Chief Executive Officer, Managing Director
William Souter
Chief Financial Officer
Address
Select House
SE 901 L 9, 109 Pitt Street
Sydney, NSW
2000
Australia